A Study to Assess the Efficacy and Safety of ISIS-SMN Rx in Patients With Later-onset Spinal Muscular Atrophy
Trial ID or NCT#
This study will test the Clinical Efficacy and Safety of ISIS-SMN Rx in patients with later-onset Spinal Muscular Atrophy.
Contact us to find out if this trial is right for you.
About this Clinical Trial
A Phase 3, Randomized, Double-Blind, Sham-Procedure Controlled Study to Assess the Clinical Efficacy and Safety of ISIS 396443 Administered Intrathecally in Patients with Later-Onset Spinal Muscular Atrophy (ISIS 396443-CS4)
Your Message Will Go ToShirley Paulose
Go Back To The Trial